TP53 and neoplasm: To determine the sensitivity of tumor cell to recombinant virus-induced apoptosis, HepG2 cells were treated with recombinant virus rNDV-P53 for 24 h, and the percent of apoptotic cells was determined by Annexin V-FITC/PI assay.